AISLE

WIPO WIPO 2019

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke AISLE wurde als Wortmarke am 04.06.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 27. Mai 2022

Markenform Wortmarke
Aktenzeichen 1489857
Länder Australien Schweiz China Europäische Gemeinschaft Israel Japan Südkorea Mexiko Norwegen Singapur Türkei
Basismarke US Nr. 88217573, 05. Dezember 2018
Anmeldedatum 04. Juni 2019
Ablaufdatum 04. Juni 2029

Markeninhaber

Suite MC 302.4 OMFR, Building
825 N.E. 13th Street
US

Markenvertreter

195 North Arlington Heights Rd, Suite 125 Buffalo Grove IL 60089 US

Waren und Dienstleistungen

35 Business consulting and management in the field of clinical trials, namely, patient enrollment tracking and monitoring, pharmaceutical and medicine tracking; business consulting and management in the field of clinical trials, namely, compilation of statistics and clinical trial data for business purposes; preparing and placing advertisements for others; providing referrals of patients for enrollment in clinical trials; business consulting and management in the field of clinical trials, namely, clinical data management; marketing consulting, namely, designing and developing advertising and marketing for others in relation to clinical trials and medical research; online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticals, biologics, diagnostic tools and medical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocols, take part in clinical studies and recruit patients to take part in clinical studies; advertising services to promote public awareness of the need for improved prevention and treatment of illnesses, and for improved health care quality and efficiency; advertising services to promote awareness of the need for assuring patients safe access to affordable medicine by means of public advocacy; advertising services to promoting technical and scientific investigation, research, and experimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticals, diagnostic tools, biomarkers and medical devices; advertising services to promote awareness of scientific, research and medical advances by means of public advocacy; systemization of information in the field of patient medical information designed to facilitate patient-authorized, hipaa-compliant sharing into computer databases and maintenance of patient medical information amongst a patient's doctors such that this information can be directly inserted into the doctor's medical reports as a means of increasing medical record generation efficiency and accuracy
42 Medical and scientific research and development in the field of medicine; medical and scientific research in the prevention, treatment, management of illness and health care delivery; medical and scientific research in the field of illness and diagnosis; technical research in the field of pharmaceutical studies; pharmaceutical product evaluation; development of pharmaceutical tools, preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; medical laboratories; scientific and technological services and research and design relating thereto, namely, scientific analysis in the fields of pharmaceutical and medical device and diagnostics development; scientific research for medical purposes; design and development of computer software; research services for medical and pharmaceutical purposes; design and development of new products and services for others; design and development of computer tracking and diagnostic tools; conducting clinical trials for others; medical laboratory services; providing information about the results of clinical trials for pharmaceutical products; electronic data storage; working on and evaluation of biomarkers and diagnostic products; providing temporary use of non-downloadable software to enables users to share data in the field of healthcare via an online network service; providing temporary use of non-downloadable software via the Internet as an application service provider [ASP] services, namely, hosting computer software applications of others in the field of knowledge management for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
09. Mai 2022 2022/21 Gaz MX Ablehnung
25. November 2021 2021/47 Gaz JP Ablehnung
13. Juli 2021 2021/31 Gaz AU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
06. Januar 2021 2021/1 Gaz KR Ablehnung
23. Dezember 2020 2020/52 Gaz TR Ablehnung
03. Dezember 2020 2020/49 Gaz JP Ablehnung
04. September 2020 2020/37 Gaz NO Ablehnung
27. August 2020 2020/35 Gaz CH Ablehnung
14. Juli 2020 2020/29 Gaz KR Ablehnung
02. Juli 2020 2020/28 Gaz IL Ablehnung
16. Juni 2020 2020/25 Gaz SG Ablehnung
10. März 2020 2020/11 Gaz EM Ablehnung
26. Januar 2020 2020/5 Gaz AU Ablehnung
29. November 2019 2019/49 Gaz CN Ablehnung
04. Juni 2019 2019/38 Gaz US Eintragung

ID: 141489857